174 related articles for article (PubMed ID: 5234417)
1. [Therapy of malignant hemopathies].
Clément F
Praxis; 1966 Jun; 55(24):680-5. PubMed ID: 5234417
[No Abstract] [Full Text] [Related]
2. [Drug therapy in hemoblastosis].
Bischof B
Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
[No Abstract] [Full Text] [Related]
3. [Use of bruneomycin in hematologic clinic].
Petrov NS
Antibiotiki; 1969 Jan; 14(1):81-6. PubMed ID: 5253410
[No Abstract] [Full Text] [Related]
4. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
5. [Enzyme therapy of hemoblastosis with L-asparaginase].
Pietschmann H; Kolarz G
Wien Z Inn Med; 1969; 50(4):148-56. PubMed ID: 5262208
[No Abstract] [Full Text] [Related]
6. [Experience of use of bruneomycin in leukemia].
Krasovskiĭ II; Kudinov VG
Antibiotiki; 1969 Jan; 14(1):77-81. PubMed ID: 5253409
[No Abstract] [Full Text] [Related]
7. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
8. [Acute leukemia and myeloma].
Riedler GF; Vorburger E; Maier C
Schweiz Med Wochenschr; 1972 Nov; 102(44):1592-4. PubMed ID: 4509370
[No Abstract] [Full Text] [Related]
9. Adrenal steroids in the treatment of malignant hematologic disease.
Cline MJ
Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
[No Abstract] [Full Text] [Related]
10. [Complications during treatment of blood diseases with corticosteroid hormonal preparations].
Latysh VN; Khludeev NI
Sov Med; 1974 Jun; 37(6):91-5. PubMed ID: 4527064
[No Abstract] [Full Text] [Related]
11. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Marcolongo R; Bianco G; Di Paolo N; Bravi A
Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
[No Abstract] [Full Text] [Related]
12. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
Böhnel J; Stacher A
Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
[No Abstract] [Full Text] [Related]
13. The effects of heterologous immune globulins upon human cancer in vivo.
Sekla B; Holecková E; Janele J; Libánský J; Hnĕvkovský O
Neoplasma; 1967; 14(6):641-7. PubMed ID: 4169507
[No Abstract] [Full Text] [Related]
14. [Therapy of hematologic diseases using androgens].
Sánchez-Medal L
Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
[No Abstract] [Full Text] [Related]
15. [Treatment of acute leukemia].
Barry A; Delage JM
Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
[No Abstract] [Full Text] [Related]
16. [Indomethacin and hematopoiesis. Antipyretic and antiphlogistic effects in hemoblastoses and various uncommon diseases].
Treske U
Med Klin; 1968 Mar; 63(9):344-6. PubMed ID: 5247178
[No Abstract] [Full Text] [Related]
17. [Use of Imiphos in diseases of the blood system].
Pinus AG
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):26-31. PubMed ID: 5260223
[No Abstract] [Full Text] [Related]
18. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
19. [Use of L-asparaginase in the treatment of leukosis].
Smirnov AN
Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):62. PubMed ID: 5284456
[No Abstract] [Full Text] [Related]
20. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
